Total Payments
$362,119
2024 Payments
$52,538
Companies
59
Transactions
1,456
Medicare Patients
3,985
Medicare Billing
$558,583
Payment Breakdown by Category
Other$293,925 (81.2%)
Travel$33,268 (9.2%)
Food & Beverage$29,874 (8.2%)
Consulting$4,364 (1.2%)
Education$687.54 (0.2%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $236,168 | 113 | 65.2% |
| Compensation for serving as faculty or as a speaker for a medical education program | $54,357 | 30 | 15.0% |
| Travel and Lodging | $33,268 | 129 | 9.2% |
| Food and Beverage | $29,874 | 1,163 | 8.2% |
| Consulting Fee | $4,364 | 4 | 1.2% |
| Honoraria | $3,400 | 1 | 0.9% |
| Education | $687.54 | 16 | 0.2% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Novo Nordisk Inc | $196,229 | 375 | $0 (2024) |
| Merck Sharp & Dohme LLC | $40,234 | 90 | $0 (2023) |
| Insulet Corporation | $36,116 | 124 | $0 (2024) |
| Dexcom, Inc. | $35,240 | 52 | $0 (2024) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $13,099 | 37 | $0 (2022) |
| Amryt Pharma Holdings Ltd | $9,259 | 11 | $0 (2023) |
| Lilly USA, LLC | $4,900 | 91 | $0 (2024) |
| Chiesi USA, Inc. | $4,896 | 9 | $0 (2024) |
| Abbott Laboratories | $3,881 | 47 | $0 (2024) |
| Valeritas, Inc. | $3,451 | 29 | $0 (2019) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $52,538 | 218 | Insulet Corporation ($28,516) |
| 2023 | $40,021 | 174 | Novo Nordisk Inc ($12,322) |
| 2022 | $82,488 | 217 | Novo Nordisk Inc ($64,701) |
| 2021 | $43,552 | 139 | Novo Nordisk Inc ($40,108) |
| 2020 | $47,834 | 103 | Novo Nordisk Inc ($42,437) |
| 2019 | $44,928 | 194 | Novo Nordisk Inc ($27,306) |
| 2018 | $28,763 | 200 | Merck Sharp & Dohme Corporation ($25,015) |
| 2017 | $21,995 | 211 | Boehringer Ingelheim Pharmaceuticals, Inc. ($12,910) |
All Payment Transactions
1,456 individual payment records from CMS Open Payments — Page 1 of 59
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/26/2024 | BETA BIONICS, INC. | iLet Bionic Pancreas (Device), iLet Bionic Pancreas, iLet Bionic Pancreas | Food and Beverage | In-kind items and services | $22.00 | General |
| Category: Automated insulin delivery system | ||||||
| 12/26/2024 | BETA BIONICS, INC. | iLet Bionic Pancreas (Device), iLet Bionic Pancreas, iLet Bionic Pancreas | Food and Beverage | In-kind items and services | $21.70 | General |
| Category: Automated insulin delivery system | ||||||
| 12/20/2024 | IBSA Pharma Inc. | Tirosint (Drug), Licart | Food and Beverage | Cash or cash equivalent | $22.74 | General |
| Category: Endocrinology | ||||||
| 12/18/2024 | Insulet Corporation | Omnipod (Device) | Travel and Lodging | Cash or cash equivalent | $547.95 | General |
| Category: Insulin Pump | ||||||
| 12/18/2024 | Insulet Corporation | Omnipod (Device) | Travel and Lodging | Cash or cash equivalent | $240.36 | General |
| Category: Insulin Pump | ||||||
| 12/18/2024 | Insulet Corporation | Omnipod (Device) | Food and Beverage | Cash or cash equivalent | $111.45 | General |
| Category: Insulin Pump | ||||||
| 12/17/2024 | Insulet Corporation | Omnipod (Device) | Compensation for serving as faculty or as a speaker for a medical education program | Cash or cash equivalent | $1,200.00 | General |
| Category: Insulin Pump | ||||||
| 12/17/2024 | Insulet Corporation | Omnipod (Device) | Compensation for serving as faculty or as a speaker for a medical education program | Cash or cash equivalent | $400.00 | General |
| Category: Insulin Pump | ||||||
| 12/17/2024 | Insulet Corporation | Omnipod (Device) | Travel and Lodging | Cash or cash equivalent | $45.20 | General |
| Category: Insulin Pump | ||||||
| 12/17/2024 | Insulet Corporation | Omnipod (Device) | Travel and Lodging | Cash or cash equivalent | $33.00 | General |
| Category: Insulin Pump | ||||||
| 12/17/2024 | Insulet Corporation | Omnipod (Device) | Travel and Lodging | Cash or cash equivalent | $33.00 | General |
| Category: Insulin Pump | ||||||
| 12/17/2024 | Insulet Corporation | Omnipod (Device) | Food and Beverage | Cash or cash equivalent | $26.05 | General |
| Category: Insulin Pump | ||||||
| 12/17/2024 | Insulet Corporation | Omnipod (Device) | Food and Beverage | Cash or cash equivalent | $22.99 | General |
| Category: Insulin Pump | ||||||
| 12/17/2024 | Insulet Corporation | Omnipod (Device) | Travel and Lodging | Cash or cash equivalent | $19.98 | General |
| Category: Insulin Pump | ||||||
| 12/17/2024 | Insulet Corporation | Omnipod (Device) | Travel and Lodging | Cash or cash equivalent | $16.75 | General |
| Category: Insulin Pump | ||||||
| 12/17/2024 | Insulet Corporation | Omnipod (Device) | Travel and Lodging | Cash or cash equivalent | $16.75 | General |
| Category: Insulin Pump | ||||||
| 12/17/2024 | Insulet Corporation | Omnipod (Device) | Food and Beverage | Cash or cash equivalent | $11.34 | General |
| Category: Insulin Pump | ||||||
| 12/17/2024 | Insulet Corporation | Omnipod (Device) | Food and Beverage | Cash or cash equivalent | $3.71 | General |
| Category: Insulin Pump | ||||||
| 12/16/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $31.58 | General |
| Category: Cardio-renal | ||||||
| 12/10/2024 | Insulet Corporation | Omnipod (Device) | Travel and Lodging | Cash or cash equivalent | $275.33 | General |
| Category: Insulin Pump | ||||||
| 12/10/2024 | Insulet Corporation | Omnipod (Device) | Food and Beverage | Cash or cash equivalent | $41.63 | General |
| Category: Insulin Pump | ||||||
| 12/10/2024 | Insulet Corporation | Omnipod (Device) | Travel and Lodging | Cash or cash equivalent | $36.00 | General |
| Category: Insulin Pump | ||||||
| 12/10/2024 | Insulet Corporation | Omnipod (Device) | Travel and Lodging | Cash or cash equivalent | $26.80 | General |
| Category: Insulin Pump | ||||||
| 12/10/2024 | Insulet Corporation | Omnipod (Device) | Travel and Lodging | Cash or cash equivalent | $23.51 | General |
| Category: Insulin Pump | ||||||
| 12/10/2024 | Insulet Corporation | Omnipod (Device) | Food and Beverage | Cash or cash equivalent | $21.15 | General |
| Category: Insulin Pump | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 13 | 1,091 | 4,036 | $333,596 | $149,749 |
| 2022 | 12 | 1,033 | 4,073 | $336,999 | $148,863 |
| 2021 | 10 | 989 | 3,727 | $318,405 | $144,674 |
| 2020 | 12 | 872 | 2,650 | $297,219 | $115,297 |
Total Patients
3,985
Total Services
14,486
Medicare Billing
$558,583
Procedure Codes
47
All Medicare Procedures & Services
47 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| J0897 | Injection, denosumab, 1 mg | Office | 2023 | 28 | 2,280 | $68,400 | $42,354 | 61.9% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 260 | 440 | $94,160 | $40,764 | 43.3% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 137 | 234 | $66,971 | $30,722 | 45.9% |
| 76536 | Ultrasound scan of head and neck soft tissue | Office | 2023 | 92 | 101 | $24,644 | $7,910 | 32.1% |
| 95251 | Continuous monitoring of blood sugar level in tissue fluid using sensor under skin with interpretation and report | Office | 2023 | 133 | 269 | $23,134 | $7,073 | 30.6% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 78 | 99 | $14,454 | $5,940 | 41.1% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 51 | 51 | $16,983 | $5,922 | 34.9% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2023 | 22 | 22 | $9,064 | $3,278 | 36.2% |
| 10005 | Fine needle aspiration biopsy using ultrasound guidance, first growth | Office | 2023 | 11 | 14 | $3,948 | $1,519 | 38.5% |
| 99231 | Subsequent hospital care with straightforward or low level of medical decision making, per day, if using time, at least 25 minutes | Facility | 2023 | 15 | 34 | $2,652 | $1,376 | 51.9% |
| 82962 | Blood glucose (sugar) test performed by hand-held instrument | Office | 2023 | 217 | 407 | $3,663 | $1,297 | 35.4% |
| G0108 | Diabetes outpatient self-management training services, individual, per 30 minutes | Office | 2023 | 11 | 22 | $2,310 | $905.52 | 39.2% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2023 | 36 | 63 | $3,213 | $689.45 | 21.5% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 301 | 563 | $120,482 | $51,154 | 42.5% |
| J0897 | Injection, denosumab, 1 mg | Office | 2022 | 31 | 2,340 | $70,200 | $40,061 | 57.1% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 101 | 173 | $49,651 | $23,590 | 47.5% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 66 | 66 | $21,978 | $7,713 | 35.1% |
| 76536 | Ultrasound scan of head and neck soft tissue | Office | 2022 | 76 | 92 | $22,448 | $7,258 | 32.3% |
| 95251 | Continuous monitoring of blood sugar level in tissue fluid using sensor under skin with interpretation and report | Office | 2022 | 108 | 223 | $19,178 | $5,976 | 31.2% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 55 | 79 | $11,534 | $5,207 | 45.1% |
| 10005 | Fine needle aspiration biopsy using ultrasound guidance, first growth | Office | 2022 | 20 | 25 | $7,050 | $2,696 | 38.2% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2022 | 15 | 15 | $6,180 | $2,509 | 40.6% |
| 82962 | Blood glucose (sugar) test performed by hand-held instrument | Office | 2022 | 211 | 422 | $3,798 | $1,357 | 35.7% |
| 99231 | Follow-up hospital inpatient care per day, typically 15 minutes | Facility | 2022 | 14 | 25 | $1,950 | $786.80 | 40.3% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2022 | 35 | 50 | $2,550 | $556.58 | 21.8% |
About Dr. Ania Janicka, D.O
Dr. Ania Janicka, D.O is a Endocrinology, Diabetes & Metabolism healthcare provider based in Hudson, Florida. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 09/05/2007. The National Provider Identifier (NPI) number assigned to this provider is 1538353305.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Ania Janicka, D.O has received a total of $362,119 in payments from pharmaceutical and medical device companies, with $52,538 received in 2024. These payments were reported across 1,456 transactions from 59 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($236,168).
As a Medicare-enrolled provider, Janicka has provided services to 3,985 Medicare beneficiaries, totaling 14,486 services with total Medicare billing of $558,583. Data is available for 4 years (2020–2023), covering 47 distinct procedure/service records.
Ad
Practice Information
- Specialty Endocrinology, Diabetes & Metabolism
- Other Specialties Diabetes & Metabolism
- Location Hudson, FL
- Active Since 09/05/2007
- Last Updated 09/05/2007
- Taxonomy Code 207RE0101X
- Entity Type Individual
- NPI Number 1538353305
Products in Payments
- Ozempic (Drug) $66,550
- Rybelsus (Drug) $56,842
- RYBELSUS (Drug) $46,430
- STEGLATRO (Drug) $36,536
- Omnipod (Device) $36,116
- DEXCOM G7 GSS (161) (Medical Supply) $17,486
- JARDIANCE (Drug) $16,323
- Dexcom G6 Transmitter (Medical Supply) $15,642
- MYCAPSSA (Drug) $14,156
- Tresiba (Drug) $11,253
- Xultophy 100/3.6 (Drug) $5,525
- V-GO (Device) $5,356
- FREESTYLE LIBRE 3 (Device) $1,950
- DEXCOM G6 TRANSMITTER (Device) $1,939
- Minimed 670G System (Device) $1,836
- FREESTYLE LIBRE 2 (Device) $1,222
- Korlym (Drug) $1,168
- EVENITY (Biological) $660.30
- FARXIGA (Drug) $578.34
- INVOKANA (Drug) $569.28
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Endocrinology, Diabetes & Metabolism Doctors in Hudson
Dr. Antonio Pinero-Pilona, M.d, M.D
Endocrinology, Diabetes & Metabolism — Payments: $285,446
Endocrinology, Diabetes & Metabolism $285,446
Dr. Jesus Penabad, M.d, M.D
Endocrinology, Diabetes & Metabolism — Payments: $59,931
Endocrinology, Diabetes & Metabolism $59,931
Dr. Talal Faris, M.d, M.D
Endocrinology, Diabetes & Metabolism — Payments: $57,673
Endocrinology, Diabetes & Metabolism $57,673
Monica Plazarte, Do, DO
Endocrinology, Diabetes & Metabolism — Payments: $24,870
Endocrinology, Diabetes & Metabolism $24,870
Anna Szafran-Swietlik, M.d, M.D
Endocrinology, Diabetes & Metabolism — Payments: $17,508
Endocrinology, Diabetes & Metabolism $17,508
Dr. Lusiana Loman, M.d, M.D
Endocrinology, Diabetes & Metabolism — Payments: $6,316
Endocrinology, Diabetes & Metabolism $6,316